N
Patient 1
ADDITIONAL PRODUCT CODE: FMF INVESTIGATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE PROVIDED.
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HARVEST TERUMO | BMAC2 120-01, BONE MARROW ASPIRATE CONCENTRATE PROCEDU | TERUMO BCT | JQC | 51423 | 11Z9949 | R | N |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2017-11-22 | 0 | 1. O |
Patient 1
ADDITIONAL PRODUCT CODE: FMF INVESTIGATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE PROVIDED.
Patient 1
UPON REVIEW OF THE INFORMATION PROVIDED BY THE DISTRIBUTOR, IT WAS DISCOVERED THAT AN EXPIRED BONE MARROW ASPIRATE CONCENTRATE (BMAC) DISPOSABLE WAS USED ON A PATIENT. THE BMAC DISPOSABLE SET WAS LABELED WITH AN EXPIRATION DATE OF 10/01/2017. THE PROCEDURE WAS PERFORMED ON (B)(6) 2017. IT IS UNKNOWN AT THIS TIME IF MEDICAL INTERVENTION WAS REQUIRED FOR THIS EVENT. PATIENT WEIGHT IS NOT AVAILABLE AT THIS TIME. PATIENT OUTCOME IS NOT AVAILABLE AT THIS TIME. THE BMAC DISPOSABLES SET IS NOT AVAILABLE FOR RETURN BECAUSE IT WAS DISCARDED BY THE CUSTOMER.